398 related articles for article (PubMed ID: 28300426)
1. Soluplus/TPGS mixed micelles for dioscin delivery in cancer therapy.
Zhao J; Xu Y; Wang C; Ding Y; Chen M; Wang Y; Peng J; Li L; Lv L
Drug Dev Ind Pharm; 2017 Jul; 43(7):1197-1204. PubMed ID: 28300426
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of a novel drug delivery: Soluplus
Ding Y; Wang C; Wang Y; Xu Y; Zhao J; Gao M; Ding Y; Peng J; Li L
Drug Dev Ind Pharm; 2018 Sep; 44(9):1409-1416. PubMed ID: 29718714
[TBL] [Abstract][Full Text] [Related]
3. Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
Bernabeu E; Gonzalez L; Cagel M; Gergic EP; Moretton MA; Chiappetta DA
Colloids Surf B Biointerfaces; 2016 Apr; 140():403-411. PubMed ID: 26780253
[TBL] [Abstract][Full Text] [Related]
4. Polymeric mixed micelles for delivery of curcumin to multidrug resistant ovarian cancer.
Saxena V; Hussain MD
J Biomed Nanotechnol; 2013 Jul; 9(7):1146-54. PubMed ID: 23909128
[TBL] [Abstract][Full Text] [Related]
5. Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to breast and multidrug-resistant cancer.
Saxena V; Hussain MD
Int J Nanomedicine; 2012; 7():713-21. PubMed ID: 22359450
[TBL] [Abstract][Full Text] [Related]
6. Mixed micelles of TPGS and Soluplus
Wang Y; Ding Y; Xu Y; Wang C; Ding Y; Gao M; Ma C; Ma X; Li L
Pharm Dev Technol; 2020 Sep; 25(7):865-873. PubMed ID: 32266855
[TBL] [Abstract][Full Text] [Related]
7. Improved solubility and oral bioavailability of apigenin via Soluplus/Pluronic F127 binary mixed micelles system.
Zhang Z; Cui C; Wei F; Lv H
Drug Dev Ind Pharm; 2017 Aug; 43(8):1276-1282. PubMed ID: 28358225
[TBL] [Abstract][Full Text] [Related]
8. Improved oral bioavailability and therapeutic efficacy of dabigatran etexilate via Soluplus-TPGS binary mixed micelles system.
Hu M; Zhang J; Ding R; Fu Y; Gong T; Zhang Z
Drug Dev Ind Pharm; 2017 Apr; 43(4):687-697. PubMed ID: 28032534
[TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin and doxorubicin co-loaded Soluplus
Wang Y; Ding Y; Zhao J; Wang C; Gao M; Chi X; Zhang B; Ma X; Li L
Pharm Dev Technol; 2019 Nov; 24(9):1125-1132. PubMed ID: 31305197
[TBL] [Abstract][Full Text] [Related]
10. Soluplus
Ding Y; Ding Y; Wang Y; Wang C; Gao M; Xu Y; Ma X; Wu J; Li L
Pharm Dev Technol; 2020 Jan; 25(1):107-115. PubMed ID: 31603017
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of pH-responsive folate-functionalized poloxamer 407-TPGS-mixed micelles on targeted delivery of anticancer drugs.
Butt AM; Mohd Amin MC; Katas H
Int J Nanomedicine; 2015; 10():1321-34. PubMed ID: 25709451
[TBL] [Abstract][Full Text] [Related]
12. A glucose-targeted mixed micellar formulation outperforms Genexol in breast cancer cells.
Moretton MA; Bernabeu E; Grotz E; Gonzalez L; Zubillaga M; Chiappetta DA
Eur J Pharm Biopharm; 2017 May; 114():305-316. PubMed ID: 28192249
[TBL] [Abstract][Full Text] [Related]
13. Folic acid-functionalized drug delivery platform of resveratrol based on Pluronic 127/D-α-tocopheryl polyethylene glycol 1000 succinate mixed micelles.
Hao J; Tong T; Jin K; Zhuang Q; Han T; Bi Y; Wang J; Wang X
Int J Nanomedicine; 2017; 12():2279-2292. PubMed ID: 28392687
[TBL] [Abstract][Full Text] [Related]
14. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, and pharmacokinetics study of a novel genistein-loaded mixed micelles system.
Shen H; He D; Wang S; Ding P; Wang J; Ju J
Drug Dev Ind Pharm; 2018 Sep; 44(9):1536-1542. PubMed ID: 29848136
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin.
Gao Y; Li LB; Zhai G
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):194-9. PubMed ID: 18325744
[TBL] [Abstract][Full Text] [Related]
17. Preparation, evaluation and metabolites study in rats of novel amentoflavone-loaded TPGS/soluplus mixed nanomicelles.
Feng X; Chen Y; Li L; Zhang Y; Zhang L; Zhang Z
Drug Deliv; 2020 Dec; 27(1):137-150. PubMed ID: 31913733
[TBL] [Abstract][Full Text] [Related]
18. Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus(®)-Solutol(®) HS15 binary mixed micelles system.
Hou J; Sun E; Sun C; Wang J; Yang L; Jia XB; Zhang ZH
Int J Pharm; 2016 Oct; 512(1):186-193. PubMed ID: 27567930
[TBL] [Abstract][Full Text] [Related]
19. Mixed micelles for encapsulation of doxorubicin with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines versus Doxil
Cagel M; Bernabeu E; Gonzalez L; Lagomarsino E; Zubillaga M; Moretton MA; Chiappetta DA
Biomed Pharmacother; 2017 Nov; 95():894-903. PubMed ID: 28903185
[TBL] [Abstract][Full Text] [Related]
20. Enhancing breast cancer treatment: Comprehensive study of gefitinib-loaded poloxamer 407/TPGS mixed micelles through design, development, in-silico modelling, In-Vitro testing, and Ex-Vivo characterization.
Chary PS; Bansode A; Rajana N; Bhavana V; Singothu S; Sharma A; Guru SK; Bhandari V; Mehra NK
Int J Pharm; 2024 May; 657():124109. PubMed ID: 38626846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
